Elmarie Bodes

Elmarie Bodes is an accomplished professional with extensive experience in strategy implementation and business transformation, particularly during tenure at AstraZeneca from November 2016 to April 2021. As Senior Director, Bodes led strategic transformation initiatives, contributing to global growth and innovation through the Growth Through Innovation Ambition 2030 Strategy PMO. Previously, as Director of Business Transformation, Bodes optimized clinical trial processes by redesigning 27 processes across various divisions. In the role of Portfolio Management Director, focus was on implementing Risk-based Quality Management and managing multimillion-dollar budgets. Elmarie Bodes holds an M.B.A. from The Wharton School, specializing in Entrepreneurship, Strategy, and Finance, and a PhD in Toxicology from UNC School of Medicine, with research centered on carcinogenesis and DNA repair mechanisms.